Nautilus Biotechnology, Inc.
NAUT
$1.75
-$0.10-5.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.70M | 7.31M | 7.16M | 6.81M | 8.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.10M | 18.84M | 19.98M | 19.10M | 20.79M |
| Operating Income | -17.10M | -18.84M | -19.98M | -19.10M | -20.79M |
| Income Before Tax | -15.03M | -16.61M | -17.59M | -16.45M | -18.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.03M | -16.61M | -17.59M | -16.45M | -18.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.03M | -16.61M | -17.59M | -16.45M | -18.01M |
| EBIT | -17.10M | -18.84M | -19.98M | -19.10M | -20.79M |
| EBITDA | -16.64M | -18.38M | -19.55M | -18.59M | -20.28M |
| EPS Basic | -0.12 | -0.13 | -0.14 | -0.13 | -0.14 |
| Normalized Basic EPS | -0.07 | -0.08 | -0.10 | -0.08 | -0.09 |
| EPS Diluted | -0.12 | -0.13 | -0.14 | -0.13 | -0.14 |
| Normalized Diluted EPS | -0.07 | -0.08 | -0.10 | -0.08 | -0.09 |
| Average Basic Shares Outstanding | 126.20M | 126.14M | 125.80M | 125.45M | 125.32M |
| Average Diluted Shares Outstanding | 126.20M | 126.14M | 125.80M | 125.45M | 125.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |